TISSUE REGENIX GROUP

TRX
Delayed Quote. Delayed  - 01/15 11:35:25 am
0.53GBX --.--%

Turn to zoom
Prev.0.5300
Open0.5300
High0.5400
Low0.5200
Volume13 565 135
Latest news
11/17
02/04
05/2015
Chart TISSUE REGENIX GROUP PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBearish
Resistance0,570,570,58
Spread/Res.-7,0%-7,0%-7,8%
Spread/Supp.6,2%20%71%
Support0,500,440,31
Financials
Sales 2020 12,5 M 17,0 M 17,0 M
Net income 2020 -5,10 M -6,93 M -6,93 M
Net Debt 2020 8,00 M 10,9 M 10,9 M
P/E ratio 2020 -5,30x
Yield 2020 -
Capitalization 37,2 M 50,6 M 50,5 M
EV / Sales 2020 3,62x
EV / Sales 2021 2,51x
Nbr of Employees 99
Free-Float 84,6%
Company
Tissue Regenix Group plc is a medical technology company. The Company is engaged in the development of regenerative products to make replacement native tissue using biological (human and animal) tissues. It operates through Cardiac, Wound Care and Orthopaedics divisions. Its decellularisation...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2021-06-10 Earnings Release

Income Statement Evolution
Consensus
Mean consensus HOLD
Number of Analysts 2
Average target price 0,90 GBX
Last Close Price 0,53 GBX
Spread / Highest target 69,8%
Spread / Average Target 69,8%
Spread / Lowest Target 69,8%